Brandinium

Trademark search for:

IDRELAST

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2008-05-30 — Application filed
  • 2008-06-03 — Application filed
  • 2008-09-11 — Suspension letter written
  • 2008-09-11 — Notification of letter of suspension e-mailed
  • 2008-09-11 — Assigned to examiner
  • 2008-09-11 — Letter of suspension e-mailed
  • 2009-03-11 — Assigned to lie
  • 2009-03-11 — Suspension checked - to attorney for action
  • 2009-03-30 — Suspension inquiry written
  • 2009-03-30 — Inquiry to suspension e-mailed
  • 2009-03-30 — Notification of inquiry as to suspension e-mailed
  • 2009-09-23 — Teas response to suspension inquiry received
  • 2009-09-23 — Teas/email correspondence entered
  • 2009-09-23 — Correspondence received in law office
  • 2009-10-14 — Final disposition recorded
  • 2009-10-14 — Final disposition recorded
  • 2009-10-14 — Final disposition recorded
  • 2010-04-14 — Examiners amendment -written
  • 2010-04-14 — Office action issued
  • 2010-04-14 — Examiners amendment e-mailed
  • 2010-04-14 — Notification of examiners amendment e-mailed
  • 2010-04-14 — Examiner's amendment entered
  • 2010-04-19 — Teas/email correspondence entered
  • 2010-04-19 — Correspondence received in law office
  • 2010-05-10 — Approved for pub - principal register
  • 2010-05-11 — Law office publication review completed
  • 2010-06-15 — Published for opposition
  • 2010-06-15 — Official gazette publication confirmation e-mailed
  • 2010-08-31 — Registered-principal register
  • 2017-04-07 — Cancelled sec. 8 (6-yr)
  • 2017-04-07 — Final status recorded

Owner Information

AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE

Correspondent

WM. CHARLES SAUNDERS ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE # OW2
WILMINGTON, DE
UNITED STATES

Filing Details

Filing Date:
2008-05-30
Status Date:
2017-04-07
Category:
Pharmaceuticals
Filing Year:
2008

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.